(Q37489176)

20 August 2017

1 reference

title

Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. (English)

1 reference

ESMO Guidelines Working Group

20 August 2017

0 references

1 reference

V Kataja

3

0 references

series ordinal

4

object named as

ESMO Guidelines Working Group

1 reference

20 August 2017

J Bellmunt

1

1 reference

PubMed ID

19454472

20 August 2017

S Albiol

series ordinal

2

1 reference

20 August 2017

1 May 2009

1 reference

20 August 2017

1 reference

20 August 2017

20 Suppl 4

1 reference

20 August 2017

79-80

1 reference

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

20 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP136

A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP136

Very young women (<35 years) with operable breast cancer: features of disease at presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP136

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP136

Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP136

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP136

Adjuvant chemotherapy for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP136

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP136

Neoadjuvant cisplatin for advanced bladder cancer.

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001426

Identifiers

DOI

10.1093/ANNONC/MDP136

1 reference

20 August 2017

1 reference

PubMed ID

19454472